Mar 16, 2015

Posted by in Medical Danger | 0 Comments

Take Your Pick: Blood Clots or Gallbladder Disease

Women who take oral contraceptives largely do so to prevent unwanted pregnancies, and there are many options out there. They certainly did not sign up to risk potentially serious blood clots or gallbladder disease when they decided to take Yaz, Yasmin, or Ocella.

It is widely accepted that some drugs have serious adverse side effects. According to the website of Williams Kherkher, drug manufacturers are supposed to make thorough clinical trials of these drugs to find out everything they can about it before marketing it to the public. The doctors then discuss this with their patients prior to implementing treatment. If the benefits outweigh the dangers, and there are no alternatives, or the alternatives are not as effective, then it becomes an acceptable risk.

However, when the drug company fails to test their products adequately, or suppresses information about negative results, they can be held liable for any adverse side effects that may occur once a drug is already available to the public. This is what happened with the birth-control pills containing drospirenone. It included Yaz, Yasmin and Ocella, all of which significantly increased their risk for forming serious blood clots (leading to deep vein thrombosis and pulmonary embolism). Drug manufacturer Bayer failed to give adequate warning about these risks, which led to the filing of numerous personal injury lawsuits. However, blood clots is not the only problem for these women.

A 2011 study that came out in the Canadian Medical Association Journal indicated that contraceptive pills containing drospirenone was associated with a higher risk (20%) of developing gallbladder disease compared to those containing levonorgestrel and other birth control pills. The conclusion was based on the results of an analysis of the medical records of 3 million women who took birth-control pills for at least 6 months. The risk increased to 30% for women who took drospirenone for a minimum of two years.

Leave a Reply

Your email address will not be published. Required fields are marked *